Early Diagnosis

Early diagnosis of ATTRv may facilitate early treatment initiation with disease-modifying therapy. Read More ›

Early diagnosis of hereditary ATTR may facilitate early treatment initiation with disease-modifying therapy. Read More ›

While fat pad or myocardial biopsy remains the gold standard for hATTR diagnosis, this case study highlights the potential of using tendon tissue. Read More ›

Analysis of subtypes of pulmonary hypertension, and potential association with specific biomarkers and survival, suggests further studies are required. Read More ›

Case study of a 79-year-old African American female, who presented with an exacerbation of congestive heart failure, highlights the importance of diagnosis, treatment, and genetic testing. Read More ›

This case study highlights the importance of careful evaluation when determining whether a patient has AL or ATTR cardiac amyloidosis. Read More ›

At the time of common orthopedic surgeries, amyloid deposition can be detected, especially in patients aged ≥70 years, providing clinicians with an opportunity for early diagnosis. Read More ›

hATTR risk can be identified through genomic screening and guide management early on, preventing potential diagnostic and treatment delays. Read More ›


Researchers evaluated patient characteristics that may be associated with positive technetium pyrophosphate uptake and aid in the diagnosis of cardiac transthyretin amyloidosis. Read More ›

Page 1 of 2

Subscribe to Amyloidosis News

Stay up to date with Amyloidosis News & updates by subscribing to receive the free AMN e‑Newsletter.

I'd like to receive: